pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: ARTHRO Distension Plus Intensive Mobilisation in Shoulder Capsulitis
Status: COMPLETED
Conditions: Shoulder Capsulitis
Interventions: PROCEDURE: infiltration intra articular|PROCEDURE: ARTHRO distension plus intensive mobilisation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation
Status: RECRUITING
Conditions: ALS|Charcot Disease
Interventions: OTHER: Teleconsultation assisted by a physiotherapist or nurse
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda - 2012
Status: WITHDRAWN
Conditions: Nodding Syndrome
Interventions: DRUG: Pyridoxine|DRUG: Sodium Valproate|DRUG: Phenytoin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of the Epley Manoeuvre Performed in Primary Care to Treat Benign Paroxysmal Positional Vertigo
Status: COMPLETED
Conditions: Benign Positional Paroxysmal Vertigo
Interventions: PROCEDURE: PROCEDURE: EPLEY MANOEUVRE|PROCEDURE: PROCEDURE: SHAM MANOEUVRE
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy
Status: COMPLETED
Conditions: Adenoma|Polyps|Colorectal Cancer
Interventions: DEVICE: G-EYE™ colonoscopy|DEVICE: Standard Colonoscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Status: COMPLETED
Conditions: Cerebral Vein Thrombosis|Deep Vein Thrombosis|Gonadal Thrombosis|Hepatic Thrombosis|Malignant Neoplasm|Mesenteric Thrombosis|Metastatic Malignant Neoplasm|Portal Vein Thrombosis|Pulmonary Embolism|Renal Vein Thrombosis|Splenic Thrombosis|Venous Thromboembolism
Interventions: DRUG: Apixaban|DRUG: Dalteparin|OTHER: Questionnaire Administration
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: PERmixon® in LUTS Evaluation Study (PERLES)
Status: COMPLETED
Conditions: Benign Prostatic Hyperplasia (BPH)
Interventions: DRUG: Permixon® 160 mg|DRUG: Tamsulosine LP|DRUG: Placebo matching Permixon® 160 mg|DRUG: Placebo matching Tamsulosine LP
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle
Status: UNKNOWN
Conditions: Ovarian Stimulation in ICSI
Interventions: DRUG: HPFSH & HMG
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effectiveness of Reel-time Ultrasound-guided Tracheostomy and Landmark Percutaneous Dilatational Tracheostomy
Status: COMPLETED
Conditions: Tracheostomy Complication
Interventions: OTHER: retrospektif study; The effect of tracheostomy tecnique method on complications
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
Status: ACTIVE_NOT_RECRUITING
Conditions: Multiple Myeloma
Interventions: OTHER: Continued treatment adapted to the response
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock
Status: TERMINATED
Conditions: Sepsis|Septic Shock
Interventions: DRUG: Vitamin C|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluate the Effect of Lifenol in Improving Bone Status in Postmenopausal Osteopenic Women
Status: COMPLETED
Conditions: Osteopenia, Generalized
Interventions: DIETARY_SUPPLEMENT: Lifenol®|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Status: TERMINATED
Conditions: HIV Infections
Interventions: DRUG: TMC114 (darunavir) / ritonavir
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial to Assess Chelation Therapy (TACT)
Status: COMPLETED
Conditions: Coronary Artery Disease
Interventions: DRUG: EDTA|DRUG: EDTA Placebo|DIETARY_SUPPLEMENT: High Dose Vitamin|DIETARY_SUPPLEMENT: High Dose Vitamin Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Hydroxytyrosol Dietary Supplement and Prevention of Age-Related Diseases
Status: RECRUITING
Conditions: Overweight|PreDiabetes
Interventions: DIETARY_SUPPLEMENT: Group 1, hydroxytyrosol-rich extract capsule (Hytolive®)|DIETARY_SUPPLEMENT: Group 2, capsule of placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV
Status: COMPLETED
Conditions: Hepatic Steatosis|HIV-1-infection
Interventions: DRUG: Maraviroc|DRUG: Metformin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA
Status: COMPLETED
Conditions: Vulvovaginal Atrophy|Dyspareunia
Interventions: DRUG: Ospemifene
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: EMD 121974 in Treating Patients With Advanced Solid Tumors
Status: COMPLETED
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: cilengitide|OTHER: pharmacological study|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Status: COMPLETED
Conditions: Tuberous Sclerosis Complex|Epilepsy
Interventions: DRUG: TAVT-18 (sirolimus)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Effect of Ursolic Acid of Loquat Extract on Function of Muscle
Status: COMPLETED
Conditions: Sarcopenia
Interventions: DIETARY_SUPPLEMENT: UA group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Safety and Pharmacokinetics Study of FBF001
Status: COMPLETED
Conditions: Avian Influenza
Interventions: BIOLOGICAL: FBF001|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
Status: RECRUITING
Conditions: AML|MDS
Interventions: DRUG: Vibecotamab|DRUG: Dexamethasone|DRUG: Acetaminophen|DRUG: Diphenhydramine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
Status: COMPLETED
Conditions: Visual Function
Interventions: PROCEDURE: Cranial Manipulation|PROCEDURE: Sham/Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults With MCI or Mild Dementia
Status: ACTIVE_NOT_RECRUITING
Conditions: Mild Cognitive Impairment|Mild Dementia
Interventions: DEVICE: MindAhead Active|OTHER: Treatment-as-usual
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: ICBT Program for Caregivers of Persons With SCI
Status: NOT_YET_RECRUITING
Conditions: Internet-Delivered Cognitive Behavioural Therapy|Depression|Anxiety|Spinal Cord Injuries|Caregiver Burnout
Interventions: BEHAVIORAL: Internet-delivered Cognitive Behavioural Therapy(ICBT)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis
Status: COMPLETED
Conditions: Amyotrophic Lateral Sclerosis
Interventions: DRUG: TCH346
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage
Status: COMPLETED
Conditions: Knee Joint Osteoarthritis
Interventions: PROCEDURE: Arthroscopic surgery|PROCEDURE: Liposuction|DEVICE: ADRC isolation|OTHER: Intraarticular administration of autologous ADRC
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Malignant Melanoma Stage III
Interventions: DRUG: Neoadjuvant ipilimumab + nivolumab|DRUG: Adjuvant nivolumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Inpatient Versus Outpatient Rehabilitation After TKA
Status: COMPLETED
Conditions: Total Knee Arthroplasty
Interventions: OTHER: inpatient rehabilitation|OTHER: outpatient rehabilitation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584
Status: COMPLETED
Conditions: Von Hippel-Lindau Disease|CNS Hemangioblastoma|Retinal Hemangioblastoma
Interventions: DRUG: PTK787/ZK 222584
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Creation of a Small Cavity Reduces the Rate of Cement Leakage During Vertebral Body Augmentation
Status: COMPLETED
Conditions: Vertebral Body Fracture
Interventions: PROCEDURE: Vertebroplasty|PROCEDURE: Cavuplasty
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis
Status: UNKNOWN
Conditions: Bronchial Asthma|Bronchiectasis
Interventions: BIOLOGICAL: Mepolizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Status: TERMINATED
Conditions: Dry Eye Disease
Interventions: DRUG: P-321 Ophthalmic Solution|DRUG: P-321 Ophthalmic Solution placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
Status: COMPLETED
Conditions: Hyperthermia|Weather; Heat|Heat Stress|Heat Syncope|Aging
Interventions: OTHER: No cooling (control)|OTHER: Lower limb immersion|OTHER: Lower limb immersion + neck cooling
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD
Status: COMPLETED
Conditions: End-Stage Renal Disease
Interventions: DEVICE: HemoCare™ Hemodialysis System
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells
Status: COMPLETED
Conditions: Myelodysplastic Syndromes (MDS)|Chromosmal Aberrations|Karyotype Evolution|Rare Abnormalities|Cytogenetic Monitoring
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Status: UNKNOWN
Conditions: Parkinson Disease|Dyskinesia, Drug-Induced|Dyskinesias
Interventions: DRUG: Dipraglurant
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery
Status: COMPLETED
Conditions: Colonic Neoplasms|Rectal Neoplasms|Diverticulitis|Inflammatory Bowel Diseases|Rectal Prolapse
Interventions: DEVICE: Compression Anastomosis Device|OTHER: follow-up colonoscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer
Status: COMPLETED
Conditions: Solid Tumors Harboring NTRK Fusion
Interventions: DRUG: Larotrectinib (Vitrakvi, BAY2757556)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Milk Protein and Bone Health in Postmenopausal Women
Status: COMPLETED
Conditions: Bone and Bones|Osteoporosis Risk|Osteoporosis, Postmenopausal
Interventions: DIETARY_SUPPLEMENT: Milk-based protein matrix (MBPM)|DIETARY_SUPPLEMENT: Habitual dietary behaviour
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Stress-free Everyday LiFe for Children and Adolescents REsearch
Status: COMPLETED
Conditions: Mental Health|Children|Adolescent|Mindfulness|Stress
Interventions: BEHAVIORAL: School teacher training /.b
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming
Status: RECRUITING
Conditions: Anesthesia Awareness
Interventions: PROCEDURE: Group TCI|PROCEDURE: Group TIVA
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer
Status: COMPLETED
Conditions: Non Squamous Non Small Cell Lung Cancer
Interventions: DRUG: OGX-427|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mirabegron and Brown Adipose Tissue
Status: UNKNOWN
Conditions: Obesity
Interventions: DRUG: Mirabegron|OTHER: Short term mild cooling|DRUG: Placebo Oral Capsule
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status
Status: COMPLETED
Conditions: Covid19|ARDS|Functional Recovery
Interventions: OTHER: Paraclinical examination|OTHER: Clinical Examination|OTHER: Semi-directive interview|OTHER: quality of life questionnaires
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Clinical Stage III Gastric Cancer AJCC v8|Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IV Gastric Cancer AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Metastatic Gastric Adenocarcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Unresectable Gastric Adenocarcinoma|Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions: DRUG: Berzosertib|PROCEDURE: Computed Tomography Assisted Biopsy|PROCEDURE: Endoscopic Biopsy|DRUG: Irinotecan|PROCEDURE: Magnetic Resonance Imaging
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
Status: COMPLETED
Conditions: Myositis|Polymyositis|Dermatomyositis|Myositis, Inclusion Body
Interventions: PROCEDURE: MRI-oriented muscle biopsy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: EMDR Versus Imagery Rescripting for Trauma-Related Intrusions
Status: NOT_YET_RECRUITING
Conditions: Stress Disorders, Post-Traumatic|Depression
Interventions: BEHAVIORAL: Eye Movement Desensitization and Reprocessing|BEHAVIORAL: Imagery Rescripting
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section
Status: COMPLETED
Conditions: Nausea|Vomiting|Satisfaction
Interventions: DRUG: scopolamine patch|DEVICE: acupressure point P6
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy
Status: UNKNOWN
Conditions: Hepatic Encephalopathy
Interventions: DRUG: Lactulose|DRUG: Polyethylene Glycol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Treatment of Topical Ketorolac Gel in Acute Gouty Flare
Status: NOT_YET_RECRUITING
Conditions: Acute Gouty Arthritis|Acute Pain|Gout Flare
Interventions: DRUG: Ketorolac Tromethamine 15 MG/ML|DRUG: Ketorolac Tromethamine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Upper Blepharoplasty on Vision Quality in the Early Postoperative Period
Status: RECRUITING
Conditions: Excess Skin of Both Eyelids|Contrast Sensitivity|Tear Film Insufficiency of Both Eyes|Corneal Topography
Interventions: PROCEDURE: Upper blepharoplasty
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG)
Status: RECRUITING
Conditions: Glioma of Spinal Cord|Glioma of Brainstem
Interventions: DRUG: GD2 CAR T cells|DRUG: Fludarabine|DRUG: Cyclophosphamide
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice
Status: TERMINATED
Conditions: Cancer
Interventions: DEVICE: Roche DPM Module|DRUG: Atezolizumab SC|OTHER: Local SOC support
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Altering Toenail Biomechanic in Managing Ingrown Toenail.
Status: COMPLETED
Conditions: Ingrown Toenail
Interventions: PROCEDURE: Central toenail resection|PROCEDURE: Wedge toenail resection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: A Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals
Status: RECRUITING
Conditions: Pre Diabetes|Overweight
Interventions: DIETARY_SUPPLEMENT: PeptiControl™ (Low - Dose 435 mg/day)|DIETARY_SUPPLEMENT: PeptiControl™ (Mid - Dose 870 mg/day)|DIETARY_SUPPLEMENT: PeptiControl™ (High - Dose 2610 mg/day)|DIETARY_SUPPLEMENT: Placebo Microcrystalline Cellulose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma
Status: TERMINATED
Conditions: Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma
Interventions: DRUG: O6-benzylguanine|DRUG: carmustine|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Use of Low-level Laser Therapy on Children Aged One to Five Years With Energy-protein Malnutrition
Status: UNKNOWN
Conditions: Malnutrition, Child
Interventions: RADIATION: Low level Light therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
Status: TERMINATED
Conditions: Lymphoma, Non-Hodgkin
Interventions: DRUG: RO7443904|DRUG: Glofitamab|DRUG: Obinutuzumab|DRUG: Tocilizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old
Status: UNKNOWN
Conditions: Hypercholesterolemia|Hyperbilirubinemia|Hyper IgE Syndrome|Hyper Beta Lipoproteinemia|Hyper Eosinophilic Syndrome|Hyper-LDL-cholesterolemia|Gout|Diabetes|Nervous System Diseases|Neuromuscular Diseases|Cardiovascular Diseases|Urologic Diseases
Interventions: PROCEDURE: plasma exchange with albumin|PROCEDURE: plasma exchange without albumin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Lansoprazole to Treat Children With Asthma
Status: COMPLETED
Conditions: Asthma
Interventions: DRUG: Lansoprazole|DRUG: Matching placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Status: COMPLETED
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: cisplatin|DRUG: docetaxel|DRUG: fluorouracil|DRUG: leucovorin calcium
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients
Status: UNKNOWN
Conditions: Rheumatoid Arthritis
Interventions: BIOLOGICAL: GB224 10mg|BIOLOGICAL: GB224 20mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan
Status: TERMINATED
Conditions: Resected Pancreatic Cancer|Pancreatic Cancer|Adjuvant Chemotherapy
Interventions: DRUG: S-1
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Montelukast Treatment in Wheezy Infants
Status: COMPLETED
Conditions: Lung Disease, Obstructive|Signs and Symptoms, Respiratory
Interventions: DRUG: montelukast
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Early Vitrectomy for Endophthalmitis After Cataract Surgery
Status: COMPLETED
Conditions: Endophthalmitis|Cataract|Vitreous Detachment|Retinal Detachment
Interventions: PROCEDURE: Early 23-gauge pars-plana vitrectomy
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Selection of Laryngeal Mask Airway in Patients With Slender Somatotype
Status: UNKNOWN
Conditions: Size of Laryngeal Mask Airway|Body Weight|Success Rate of First Attempt|Complication
Interventions: DEVICE: Laryngeal Mask Airway
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose:
Clinical trial: A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer
Status: COMPLETED
Conditions: Prostate Cancer
Interventions: DRUG: Ibrance|DRUG: Bicalutamide|DRUG: Zoladex|DRUG: Lupron Depot
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time
Status: WITHDRAWN
Conditions: Dry Eye
Interventions: OTHER: Systane Ultra|OTHER: Optive
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Nutritional Therapy in Patients at Risk for Malnutrition and Sarcopenia in Pulmonary Rehabilitation
Status: COMPLETED
Conditions: Sarcopenia|Malnutrition
Interventions: OTHER: individual nutritional therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia
Status: NOT_YET_RECRUITING
Conditions: Patients With Schizophrenia
Interventions: DIAGNOSTIC_TEST: Therapeutic Drug Monitoring (TDM) and Pharmacogenetics (PG)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Feasibility, Acceptability and Preliminary Efficacy of a Group Intervention to Reduce Loneliness
Status: COMPLETED
Conditions: Loneliness|Social Isolation
Interventions: BEHAVIORAL: Goal-Based Cognitive Behavioural Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder
Status: COMPLETED
Conditions: Neurogenic Bladder|Urinary Tract Infection
Interventions: DRUG: Weekly Oral Cyclic Antibiotic programme
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
Status: COMPLETED
Conditions: Urologic Diseases
Interventions: DRUG: Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|DRUG: Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Tomato Juice for Health Study
Status: TERMINATED
Conditions: Healthy Volunteers
Interventions: OTHER: High Lycopene Tomato Juice With Soy Germ Extract|OTHER: Low Lycopene Tomato Juice
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer
Status: COMPLETED
Conditions: Gastric Cancer
Interventions: DRUG: Docetaxel|DRUG: Cisplatin|DRUG: Capecitabine|RADIATION: Radiation|DRUG: Capecitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Lebrikizumab in Combination With Topical Corticosteroids in Participants Having Atopic Dermatitis (AD) That Are Not Adequately Controlled or Non-eligible for Cyclosporine
Status: COMPLETED
Conditions: Dermatitis, Atopic|Eczema
Interventions: BIOLOGICAL: Lebrikizumab|DRUG: Lebrikizumab-matching Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
Status: TERMINATED
Conditions: Schizophrenia
Interventions: DRUG: Antipsychotic/Risperidone Consta
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia
Status: RECRUITING
Conditions: Gestational Trophoblastic Neoplasia|Molar Pregnancy|Gestational Trophoblastic Tumor, Non-Metastatic
Interventions: PROCEDURE: Uterine curettage|DRUG: Chemotherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Nasopharyngeal Carriage of S. Pneumoniae
Status: RECRUITING
Conditions: Nasopharyngeal Carriage|Children, Only|Antibiotic Resistant Strain
Interventions: OTHER: nasopharyngeal sample|OTHER: Stools collection or anorectal swab samples
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma
Status: COMPLETED
Conditions: Gastric Cancer, Gastroesophageal Junction Cancer
Interventions: BIOLOGICAL: Trastuzumab
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Quality of Life and Nutritional Improvements in Cirrhotic Patients
Status: TERMINATED
Conditions: Liver Cirrhosis|Hepatic Encephalopathy|Portal Hypertension
Interventions: DRUG: Rifaximin|DRUG: Lactulose|DRUG: Lactulose Placebo|DRUG: Rifaximin Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Physiotherapy on Post POEM Reflux
Status: RECRUITING
Conditions: Reflux, Gastroesophageal|Achalasia|Esophagitis
Interventions: OTHER: Physiotherapy|DRUG: Control group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
Status: COMPLETED
Conditions: Contraception
Interventions: DRUG: LPRI424 (dienogest/ethinylestradiol)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: The Effects of Neurodevelopmental Therapy on Feeding and Swallowing.
Status: COMPLETED
Conditions: Cerebral Palsy
Interventions: OTHER: Structured neck and trunk stabilization exercises|OTHER: Feeding and oral motor intervention strategies|OTHER: Caregiver training related to feeding
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Role of Platelet Rich Plasma in Enhancing Graft Take in Chronic Venous Ulcers
Status: COMPLETED
Conditions: Chronic Venous Hypertension With Ulcer and Inflammation|Chronic Ulcer of Leg or Foot
Interventions: PROCEDURE: PRP|PROCEDURE: STSG
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Status: RECRUITING
Conditions: HPV Infection
Interventions: DRUG: Gardasil 9 2 dose regimen|DRUG: Gardasil 9 3 dose regimen|DRUG: Gardasil 9 rescue dose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Comparison of Acceleromyography (AMG) and Mechanomyography (MMG) for Establishing Potency of Neuromuscular Blocking Agents
Status: COMPLETED
Conditions: Neuromuscular Blockade
Interventions: DEVICE: TOF-Watch SX (Acceleromyography)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: SINGLE|Primary Purpose: TREATMENT
Clinical trial: TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
Status: RECRUITING
Conditions: Esophageal Cancer|Esophageal Adenocarcinoma
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Paclitaxel|DRUG: Carboplatin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy
Status: COMPLETED
Conditions: Cystic Fibrosis
Interventions: OTHER: Conventional antimicrobial susceptibility testing|OTHER: Biofilm antimicrobial susceptibility testing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy
Status: COMPLETED
Conditions: Gastric Cancer
Interventions: PROCEDURE: Intracorporeal esophagojejunostomy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Culturally Adapted Psychosocial Interventions for Early Psychosis in a Low-resource Setting
Status: RECRUITING
Conditions: Psychosis
Interventions: BEHAVIORAL: CaCBT for psychosis|BEHAVIORAL: Culturally adapted Family Intervention (CulFI) for psychosis
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants
Status: COMPLETED
Conditions: Preterm Infant|Early-Onset Neonatal Sepsis|Umbilical Cord
Interventions: OTHER: Placental/Umbilical Cord Blood sample
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV
Status: COMPLETED
Conditions: HIV-1-infection|Hypertension
Interventions: OTHER: EXTRA-CVD Virtual Care
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
Status: UNKNOWN
Conditions: Primary Sclerosing Cholangitis
Interventions: DRUG: Vancomycin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Early Intervention in Preterm Infants: Short and Long Term Developmental Outcome After a Parental Training Program
Status: COMPLETED
Conditions: Premature Birth
Interventions: BEHAVIORAL: Early Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Engaging Medically Complex Veterans in Tele-Rehabilitation Using a Biobehavioral Approach
Status: COMPLETED
Conditions: Multimorbidity|Physical Deconditioning
Interventions: BEHAVIORAL: Motivational Interviewing Techniques|OTHER: Physical Therapy Interventions|OTHER: Education|OTHER: Qualitative Interview
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: EBP-SDM Training Program Empowers Nurses' Competency and Performance
Status: UNKNOWN
Conditions: Training|Nurse|Evidence-based Practice
Interventions: BEHAVIORAL: EBP training|BEHAVIORAL: SDM training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas
Status: COMPLETED
Conditions: Diabetes
Interventions: DRUG: Saxagliptin|DRUG: Saxagliptin|DRUG: Glyburide|DRUG: Placebo|DRUG: Glyburide|DRUG: Metformin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms
Status: COMPLETED
Conditions: IBS - Irritable Bowel Syndrome|Anxiety
Interventions: DIETARY_SUPPLEMENT: Arrae bloat supplement
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)
Status: UNKNOWN
Conditions: Anemia of Chronic Kidney Disease
Interventions: DRUG: EPORON|DRUG: EPREX
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Quadratus Lumborum Block in C/S
Status: COMPLETED
Conditions: Postoperative Pain|Cesarean Section Complications|Block|Patient Satisfaction
Interventions: PROCEDURE: ultrasound guıded quadratus lumborum block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study
Status: TERMINATED
Conditions: Atopic Dermatitis
Interventions: BIOLOGICAL: FB-401
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Non-returning Catheter Valve for Reducing CAUTI
Status: COMPLETED
Conditions: Catheter Associated Urinary Tract Infection|Critically Ill Patients
Interventions: DEVICE: Non-returning catheter valve|DEVICE: Conventional urine bag
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
Status: ACTIVE_NOT_RECRUITING
Conditions: Smoldering Multiple Myeloma
Interventions: DRUG: carfilzomib|DRUG: Lenalidomide|DRUG: Dexamethasone|DRUG: Melphalan
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: GOT-IT Trial: Glyceryl Trinitrate for Retained Placenta
Status: COMPLETED
Conditions: Placenta, Retained
Interventions: DRUG: Glyceryl Trinitrate|DRUG: Matched Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Docetaxel and Sirolimus in Patients With Advanced Malignancies
Status: COMPLETED
Conditions: Advanced Cancer
Interventions: DRUG: Docetaxel (Taxotere)|DRUG: Sirolimus (Rapamycin)|DRUG: Prednisone
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer
Status: COMPLETED
Conditions: Breast Neoplasms|mTor Protein
Interventions: DRUG: Tamoxifen|DRUG: Everolimus
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction
Status: COMPLETED
Conditions: Temporomandibular Joint Dysfunction|Pain|Arthrocentesis
Interventions: DRUG: Hyaluronic acid|DRUG: Corticosteroid|DRUG: Lactated Ringers
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
Status: COMPLETED
Conditions: Spinal Muscular Atrophy
Interventions: DRUG: Valproic Acid (VPA)|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG
Status: COMPLETED
Conditions: Carcinoma, Small Cell Lung
Interventions: BIOLOGICAL: BEC2 Vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
Status: NOT_YET_RECRUITING
Conditions: Progressive Multiple Sclerosis
Interventions: DEVICE: Transcranial static magnetic field stimulation (tSMS)|DEVICE: Sham Transcranial static magnetic field stimulation (tSMS)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery
Status: COMPLETED
Conditions: Kidney Function Tests
Interventions: DRUG: Hydroxyethylstarch 6% 130/0.4|OTHER: standard volume therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use
Status: UNKNOWN
Conditions: Marijuana Use|Marijuana Dependence|Tobacco Use|Alcohol Use, Unspecified
Interventions: BEHAVIORAL: Domain-Specific Episodic Future Thinking
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Status: COMPLETED
Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: DRUG: GSK573719/GW642444 125/25|DRUG: GSK573719/GW642444 62.5/25|DRUG: GSK573719|DRUG: tiotropium bromide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparative Evaluation of Simulator Based and Traditional In-surgery Laparoscopic Camera Training's Efficiency in Novices
Status: COMPLETED
Conditions: Laparoscopy|Clinical Competence
Interventions: BEHAVIORAL: Training on laparoscopic simulator in skills lab|BEHAVIORAL: Training at actual laparoscopic surgery|BEHAVIORAL: Technical instruction
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Status: WITHDRAWN
Conditions: Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: exemestane|PROCEDURE: adjuvant therapy|PROCEDURE: aromatase inhibition|PROCEDURE: conventional surgery|PROCEDURE: endocrine therapy|PROCEDURE: hormone therapy|PROCEDURE: neoadjuvant therapy|PROCEDURE: surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Status: RECRUITING
Conditions: Platinum-resistant Ovarian Cancer|Testicular Cancer|Endometrial Cancer
Interventions: DRUG: CTIM-76
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT